Premium
Interpatient Pharmacokinetic and Pharmacodynamic Variability of Carrier‐Mediated Anticancer Agents
Author(s) -
Caron W P,
Song G,
Kumar P,
Rawal S,
Zamboni W C
Publication year - 2012
Publication title -
clinical pharmacology and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.941
H-Index - 188
eISSN - 1532-6535
pISSN - 0009-9236
DOI - 10.1038/clpt.2012.12
Subject(s) - pharmacokinetics , pharmacodynamics , pharmacology , clinical pharmacology , medicine , drug , site of action , distribution (mathematics) , drug delivery , chemistry , mathematical analysis , mathematics , organic chemistry
Major advances in the field of carrier‐mediated agents (CMAs) have revolutionized drug delivery capabilities over the past decade. While providing numerous advantages over their small‐molecule counterparts (solubility, duration of exposure, and delivery to the site of action are higher), these agents display substantial variability in systemic clearance (CL) and distribution, tumor delivery, and pharmacologic effects. This review provides an overview of factors that affect the pharmacokinetics (PK) and pharmacodynamics (PD) of CMAs in preclinical models and patients. Clinical Pharmacology & Therapeutics (2012); 91 5, 802–812. doi: 10.1038/clpt.2012.12